• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性黑色素瘤患者血清中的酪氨酸酶活性。

Tyrosinase activity in the serum of patients with malignant melanoma.

作者信息

Sonesson B, Eide S, Ringborg U, Rorsman H, Rosengren E

机构信息

Department of Dermatology, University of Lund, University Hospital, Sweden.

出版信息

Melanoma Res. 1995 Apr;5(2):113-6. doi: 10.1097/00008390-199504000-00007.

DOI:10.1097/00008390-199504000-00007
PMID:7620338
Abstract

We have recently described a new method for measurement of tyrosinase activity in small amounts of human serum (100 microliters), where the purification of tyrosinase is obtained by adsorption of the enzyme to concanavalin A sepharose. The method, which measures stereospecific dopa oxidation, was used in the winter of 1992-93 for the measurement of activity in serum obtained from 30 healthy subjects and from 10 patients with melanoma metastases. The serum tyrosinase values in the 30 subjects ranged from 0.1 to 1.0 nkatal/l, and the mean value and standard deviation was 0.4 +/- 0.2 nkatal/l. In the 10 patients with melanoma, the tyrosinase serum values ranged from 1.1 to 10.6 nkal/l, and the mean value was 3.1 nkatal/l.

摘要

我们最近描述了一种测量少量人血清(100微升)中酪氨酸酶活性的新方法,该方法通过将酶吸附到伴刀豆球蛋白A琼脂糖上来纯化酪氨酸酶。这种测量立体特异性多巴氧化的方法在1992 - 1993年冬季用于测量30名健康受试者和10名黑色素瘤转移患者的血清活性。30名受试者的血清酪氨酸酶值在0.1至1.0纳 Katal/升之间,平均值和标准差为0.4±0.2纳 Katal/升。在10名黑色素瘤患者中,血清酪氨酸酶值在1.1至10.6纳 Katal/升之间,平均值为3.1纳 Katal/升。

相似文献

1
Tyrosinase activity in the serum of patients with malignant melanoma.恶性黑色素瘤患者血清中的酪氨酸酶活性。
Melanoma Res. 1995 Apr;5(2):113-6. doi: 10.1097/00008390-199504000-00007.
2
Tyrosinase activity in serum from patients with malignant melanoma.
Acta Derm Venereol. 1989;69(2):120-4.
3
Seasonal variation of tyrosinase activity in serum.血清中酪氨酸酶活性的季节性变化。
Acta Derm Venereol. 1995 Jul;75(4):283-6. doi: 10.2340/0001555575283286.
4
Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.外周血酪氨酸酶信使核糖核酸检测与恶性黑色素瘤患者的生存情况
J Natl Cancer Inst. 1996 May 1;88(9):590-4. doi: 10.1093/jnci/88.9.590.
5
Serum tyrosinase in malignant disease, its activity, and the electrophoretic patterns of the enzyme as carried by immunoglobulins'.
Cancer Res. 1979 Sep;39(9):3485-90.
6
Detection of tyrosinase mRNA from the blood of melanoma patients.检测黑色素瘤患者血液中的酪氨酸酶信使核糖核酸。
Cancer Epidemiol Biomarkers Prev. 1996 Apr;5(4):293-6.
7
Simultaneous analysis of tyrosinase mRNA and markers of tyrosinase activity in the blood of patients with metastatic melanoma.
Clin Chim Acta. 1999 Apr;282(1-2):101-13. doi: 10.1016/s0009-8981(99)00022-4.
8
Identification of melanoma metastases by tyrosinase-reverse transcription-polymerase chain reaction of fine needle aspirates.通过细针穿刺抽吸物的酪氨酸酶逆转录聚合酶链反应鉴定黑色素瘤转移灶
J Am Acad Dermatol. 1998 Dec;39(6):1030-2. doi: 10.1016/s0190-9622(98)70287-7.
9
Tyrosinase activity in the sera of patients with malignant melanoma: method and specificity.恶性黑色素瘤患者血清中的酪氨酸酶活性:方法与特异性
Int J Cancer. 1977 Nov 15;20(5):689-93. doi: 10.1002/ijc.2910200507.
10
An animal model for the survival of tyrosinase isozymes in serum.
Arch Dermatol Res. 1984;276(2):111-4. doi: 10.1007/BF00511067.

引用本文的文献

1
Melanoma's New Frontier: Exploring the Latest Advances in Blood-Based Biomarkers for Melanoma.黑色素瘤的新前沿:探索基于血液的黑色素瘤生物标志物的最新进展
Cancers (Basel). 2024 Dec 18;16(24):4219. doi: 10.3390/cancers16244219.
2
The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness.皮肤黑色素瘤侵袭性中黑色素分泌的阴暗面
Front Oncol. 2022 May 10;12:887366. doi: 10.3389/fonc.2022.887366. eCollection 2022.
3
Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship.黑色素瘤、黑色素与黑色素生成:阴阳关系
Front Oncol. 2022 Mar 14;12:842496. doi: 10.3389/fonc.2022.842496. eCollection 2022.
4
A synopsis of serum biomarkers in cutaneous melanoma patients.皮肤黑色素瘤患者血清生物标志物概述。
Dermatol Res Pract. 2012;2012:260643. doi: 10.1155/2012/260643. Epub 2012 Jan 12.
5
[Serum markers for melanoma].[黑色素瘤的血清标志物]
Hautarzt. 2005 Feb;56(2):173-84; 185-6. doi: 10.1007/s00105-004-0893-2.